CN103827129A - 盐酸表阿霉素的结晶 - Google Patents
盐酸表阿霉素的结晶 Download PDFInfo
- Publication number
- CN103827129A CN103827129A CN201280026091.5A CN201280026091A CN103827129A CN 103827129 A CN103827129 A CN 103827129A CN 201280026091 A CN201280026091 A CN 201280026091A CN 103827129 A CN103827129 A CN 103827129A
- Authority
- CN
- China
- Prior art keywords
- scope
- farmorubine hydrochloride
- alcohol
- mixture
- crystallization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
- A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (20)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102011103751.2 | 2011-05-31 | ||
DE102011103751A DE102011103751A1 (de) | 2011-05-31 | 2011-05-31 | Kristallisierung von Epirubicinhydrochlorid |
US201161493034P | 2011-06-03 | 2011-06-03 | |
US61/493034 | 2011-06-03 | ||
PCT/EP2012/002248 WO2012163508A1 (de) | 2011-05-31 | 2012-05-25 | Kristallisierung von epirubicinhydrochlorid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103827129A true CN103827129A (zh) | 2014-05-28 |
Family
ID=47173398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280026091.5A Pending CN103827129A (zh) | 2011-05-31 | 2012-05-25 | 盐酸表阿霉素的结晶 |
Country Status (14)
Country | Link |
---|---|
US (1) | US9657047B2 (zh) |
EP (1) | EP2714707B1 (zh) |
JP (2) | JP6014844B2 (zh) |
KR (1) | KR20140006092A (zh) |
CN (1) | CN103827129A (zh) |
AR (1) | AR086519A1 (zh) |
AU (1) | AU2012265238B2 (zh) |
DE (1) | DE102011103751A1 (zh) |
HR (1) | HRP20170329T1 (zh) |
HU (1) | HUE031795T2 (zh) |
PL (1) | PL2714707T3 (zh) |
RU (1) | RU2586117C2 (zh) |
TW (1) | TWI496789B (zh) |
WO (1) | WO2012163508A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104861014A (zh) * | 2015-06-03 | 2015-08-26 | 道中道(菏泽)制药有限公司 | 一种盐酸表阿霉素结晶的制备方法 |
CN109384822A (zh) * | 2017-08-11 | 2019-02-26 | 鲁南制药集团股份有限公司 | 一种盐酸表柔比星晶型及其制备方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2778171A1 (en) * | 2013-03-15 | 2014-09-17 | Synbias Pharma Ltd. | Crystalline monohydrate of epirubicin hydrochloride |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4112076A (en) * | 1975-04-30 | 1978-09-05 | Societa' Farmaceutici Italia S.P.A. | Epi-daunomycin and epi-adriamycin compounds and method of use |
EP1036797A1 (en) * | 1997-12-05 | 2000-09-20 | Mercian Corporation | Crystalline anthracycline antibiotic and process for producing the same |
CN1871249A (zh) * | 2003-07-02 | 2006-11-29 | 獀洛克斯股份有限公司 | 热稳定的结晶盐酸表柔比星及其制造方法 |
US20090099346A1 (en) * | 2003-07-02 | 2009-04-16 | Victor Matvienko | Thermally stable crystalline epirubicin hydrochloride |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4345068A (en) | 1979-11-22 | 1982-08-17 | Farmitalia Carlo Erba S.P.A. | Process for the preparation of 4'-epidaunorubicin, 3',4'-diepidaunorubicin, their doxorubicin analogs, and intermediates used in said process |
IT1155446B (it) | 1982-12-23 | 1987-01-28 | Erba Farmitalia | Procedimento per la purificazione di glucosidi antraciclinonici mediante adsobimento selettivo su resine |
GB8426672D0 (en) | 1984-10-22 | 1984-11-28 | Erba Farmitalia | Pharmaceutical compositions |
EP0848009B1 (en) | 1996-12-16 | 2000-08-16 | Pharmachemie B.V. | A process for preparing epirubicin or acid addition salts thereof from daunorubicin |
DK1034181T3 (da) | 1997-11-28 | 2006-03-20 | Dainippon Sumitomo Pharma Co | Krystallinsk amrubicinhydrochlorid |
KR20020071931A (ko) * | 2000-01-07 | 2002-09-13 | 트렌스폼 파마수티컬스 인코퍼레이티드 | 다양한 고체-형태들의 고도의 자료 처리 편성, 확인 및분석 |
US7388083B2 (en) * | 2005-03-07 | 2008-06-17 | Solux Corporation | Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics |
CA2606390A1 (en) * | 2005-05-11 | 2006-11-16 | Sicor, Inc. | Stable lyophilized anthracycline glycosides |
US8802830B2 (en) * | 2005-12-20 | 2014-08-12 | Solux Corporation | Synthesis of epirubicin from 13-dihydrodaunorubicine |
JP2007261976A (ja) * | 2006-03-28 | 2007-10-11 | Meiji Seika Kaisha Ltd | 抗腫瘍性アンスラサイクリン系抗生物質の製造法 |
PL1990405T3 (pl) | 2007-05-08 | 2018-01-31 | Provivo Oy | Genetycznie zmodyfikowane szczepy wytwarzające metabolity będące antracyklinami użyteczne jako leki przeciwnowotworowe |
JP5550644B2 (ja) | 2008-06-18 | 2014-07-16 | レクシコン ファーマシューティカルズ インコーポレイテッド | (1r,2s,3r)−1−(2−(イソオキサゾール−3−イル)−1h−イミダゾール−4−イル)ブタン−1,2,3,4−テトラオールの固体形態及びその使用方法 |
PL2301943T3 (pl) * | 2009-09-08 | 2014-06-30 | Heraeus Precious Metals Gmbh | Krystalizacja epidaunorubicyny x HCI |
KR101125460B1 (ko) * | 2010-03-24 | 2012-03-28 | 동아제약주식회사 | 에피루비신 염산염의 신규한 결정형 |
CN102120750B (zh) * | 2011-01-30 | 2013-04-03 | 山东新时代药业有限公司 | 一种盐酸表柔比星的纯化方法 |
-
2011
- 2011-05-31 DE DE102011103751A patent/DE102011103751A1/de not_active Ceased
-
2012
- 2012-05-15 US US13/471,537 patent/US9657047B2/en active Active
- 2012-05-22 AR ARP120101808A patent/AR086519A1/es not_active Application Discontinuation
- 2012-05-25 RU RU2013158684/04A patent/RU2586117C2/ru active
- 2012-05-25 HU HUE12735774A patent/HUE031795T2/en unknown
- 2012-05-25 WO PCT/EP2012/002248 patent/WO2012163508A1/de active Application Filing
- 2012-05-25 KR KR1020137031904A patent/KR20140006092A/ko active Search and Examination
- 2012-05-25 CN CN201280026091.5A patent/CN103827129A/zh active Pending
- 2012-05-25 AU AU2012265238A patent/AU2012265238B2/en active Active
- 2012-05-25 PL PL12735774T patent/PL2714707T3/pl unknown
- 2012-05-25 EP EP12735774.7A patent/EP2714707B1/de active Active
- 2012-05-25 JP JP2014513078A patent/JP6014844B2/ja active Active
- 2012-05-29 TW TW101119194A patent/TWI496789B/zh active
-
2016
- 2016-05-18 JP JP2016099985A patent/JP2016175938A/ja active Pending
-
2017
- 2017-02-27 HR HRP20170329TT patent/HRP20170329T1/hr unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4112076A (en) * | 1975-04-30 | 1978-09-05 | Societa' Farmaceutici Italia S.P.A. | Epi-daunomycin and epi-adriamycin compounds and method of use |
EP1036797A1 (en) * | 1997-12-05 | 2000-09-20 | Mercian Corporation | Crystalline anthracycline antibiotic and process for producing the same |
CN1871249A (zh) * | 2003-07-02 | 2006-11-29 | 獀洛克斯股份有限公司 | 热稳定的结晶盐酸表柔比星及其制造方法 |
US20090099346A1 (en) * | 2003-07-02 | 2009-04-16 | Victor Matvienko | Thermally stable crystalline epirubicin hydrochloride |
Non-Patent Citations (1)
Title |
---|
沈丹,等: "蒽醌类抗肿瘤抗生素与DNA相互作用探究", 《中华医院感染学杂志》, vol. 18, no. 10, 15 October 2008 (2008-10-15), pages 1368 - 1370 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104861014A (zh) * | 2015-06-03 | 2015-08-26 | 道中道(菏泽)制药有限公司 | 一种盐酸表阿霉素结晶的制备方法 |
CN109384822A (zh) * | 2017-08-11 | 2019-02-26 | 鲁南制药集团股份有限公司 | 一种盐酸表柔比星晶型及其制备方法 |
CN109384822B (zh) * | 2017-08-11 | 2021-08-03 | 鲁南制药集团股份有限公司 | 一种盐酸表柔比星晶型及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
TWI496789B (zh) | 2015-08-21 |
JP2016175938A (ja) | 2016-10-06 |
EP2714707A1 (de) | 2014-04-09 |
TW201302773A (zh) | 2013-01-16 |
PL2714707T3 (pl) | 2017-06-30 |
AU2012265238B2 (en) | 2016-05-12 |
RU2013158684A (ru) | 2015-07-10 |
US9657047B2 (en) | 2017-05-23 |
HRP20170329T1 (hr) | 2017-04-21 |
KR20140006092A (ko) | 2014-01-15 |
AU2012265238A1 (en) | 2014-01-09 |
WO2012163508A1 (de) | 2012-12-06 |
JP6014844B2 (ja) | 2016-10-26 |
US20120309948A1 (en) | 2012-12-06 |
DE102011103751A1 (de) | 2012-12-06 |
AR086519A1 (es) | 2013-12-18 |
HUE031795T2 (en) | 2017-08-28 |
RU2586117C2 (ru) | 2016-06-10 |
JP2014515381A (ja) | 2014-06-30 |
EP2714707B1 (de) | 2016-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3596042B1 (en) | Crystal forms of amino lipids | |
EP2882687B1 (en) | Method for producing stabilized amorphous calcium carbonate | |
JP2017025068A (ja) | エルタペネムナトリウムの結晶形およびその調製方法 | |
JP2021036002A (ja) | 6’−シアリルラクトースナトリウム塩の結晶およびその製造方法 | |
US20100168117A1 (en) | A process for the preparation of the stable, amorphous calcium salt of (6s)-n(5)-methyl-5,6,7,8-tetrahydrofolic acid | |
CN103827129A (zh) | 盐酸表阿霉素的结晶 | |
KR20180113822A (ko) | 1-[(4-메틸-퀴나졸린-2-일)메틸]-3-메틸-7-(2-부틴-1-일)-8-(3-(r)-아미노-피페리딘-1-일)-크산틴의 신규한 결정형 및 그의 제조방법 | |
EP3617191B9 (en) | Method for manufacturing diastereomer of citric acid derivative | |
WO2004048385A2 (en) | A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate | |
JP6392320B2 (ja) | 結晶性3’,5’−サイクリックジグアニル酸 | |
CN111094313B (zh) | 盐酸伊达比星一水合物的晶型 | |
KR20200134928A (ko) | 발사르탄/사쿠비트릴 3소듐염 수화물의 결정형 및 그 제조방법 | |
WO2023072890A1 (en) | Process for the preparation of sucrose octasulfate octakistriethylammonium salt (tasos) powder and uses thereof | |
JP7201263B2 (ja) | Cyclic-di-AMPナトリウム塩結晶 | |
KR101019201B1 (ko) | 덱시부프로펜 알지닌염의 제조방법 | |
CN106957311B (zh) | 雷替曲塞的溶剂化物及其制备方法 | |
TW202227387A (zh) | 單水合曲前列環素晶體及其製備方法 | |
EP2776433A1 (en) | Pures-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,-5h-benzo[i,j]quinolizine-2- carboxylic acid l-arginine salt tetrahydrate and a process for its preparation | |
WO2004035567A1 (en) | High purity ondansetron hydrochloride dihydrate and process for its synthesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20161110 Address after: German Weddle Applicant after: HERAEUS DEUTSCHLAND GmbH & Co.KG Address before: Hanau Applicant before: HERAEUS DEUTSCHLAND GmbH & Co.KG Effective date of registration: 20161110 Address after: Hanau Applicant after: HERAEUS DEUTSCHLAND GmbH & Co.KG Address before: Hanau Applicant before: HERAEUS PRECIOUS METALS GmbH & Co.KG |
|
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140528 |
|
RJ01 | Rejection of invention patent application after publication |